Folia Pharmacologica Japonica 2005-01-01

[Raloxifene hydrochloride (Evista Tablet 60 mg) for postmenopausal osteoporosis: mode of action and clinical efficacy].

Hiroyuki Kobayashi, Etsuro Hamaya

Index: Nippon. Yakurigaku Zasshi. 125(1) , 37-48, (2005)

Full Text: HTML

Related Compounds

Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase.

2014-08-01

[Drug Metab. Dispos. 42(8) , 1326-33, (2014)]

Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.

2015-01-01

[J. Steroid Biochem. Mol. Biol. 145 , 85-93, (2015)]

Bioluminescent cell-based NAD(P)/NAD(P)H assays for rapid dinucleotide measurement and inhibitor screening.

2014-01-01

[Assay Drug Dev. Technol. 12(9-10) , 514-26, (2014)]

Risk-benefit profiles of women using tamoxifen for chemoprevention.

2015-01-01

[J. Natl. Cancer Inst. 107(1) , 354, (2015)]

Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis.

2014-01-01

[Arch. Osteoporos. 9 , 189, (2014)]